PpI am currently partnered with an innovative biotech company advancing therapies in hematologic malignancies. As we prepare to initiate a global Phase 3 pivotal study inmyelofibrosis, we are seeking an experiencedMedical Directoron a contract basis to provide strategic medical leadership and clinical oversight throughout this critical development phase. /p h3Position Summary /h3 pThe Medical Director will play a key role in the planning, execution, and medical oversight of the Phase 3 trial. This position requires expertise in hematology, ideally with direct experience in myelofibrosis or related myeloproliferative neoplasms. The successful candidate will work cross-functionally with clinical operations, regulatory, pharmacovigilance, and external partners to ensure the trial’s success. /p h3Key Responsibilities /h3 ul liProvide medical and scientific leadership for the design, execution, and reporting of the Phase 3 myelofibrosis trial. /li liServe as the primary medical contact for internal teams, investigators, and external stakeholders. /li liOversee patient safety and ensure compliance with ICH-GCP, FDA, and EMA regulations. /li liSupport clinical data analysis, review, and interpretation; contribute to regulatory submissions and clinical study reports. /li liEngage with key opinion leaders (KOLs) in hematology to inform trial strategy and execution. /li liCollaborate with the CRO and site investigators to ensure high-quality data collection and protocol adherence. /li /ul h3Qualifications /h3 ul liMD or equivalent with board certification in hematology or oncology preferred. /li liSignificant experience (10 years) in clinical development, with a strong focus on late-stage trials in hematology. /li liPrior involvement in Phase 3 studies; experience inmyelofibrosisormyeloproliferative neoplasmsis highly desirable. /li liProven ability to manage cross-functional clinical teams and interact effectively with CROs and regulators. /li liStrong analytical, strategic thinking, and communication skills. /li /ul /p #J-18808-Ljbffr